We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
BIO-RAD LABORATORIES

Download Mobile App





New Research Shows Self-Collected Tests Perform Similarly to Provider-Collected Tests for Detecting STIs

By LabMedica International staff writers
Posted on 27 Jul 2023
Print article
Image: Two breaking studies on self-collected tests were presented at AACC 2023 (Photo courtesy of LetsGetChecked)
Image: Two breaking studies on self-collected tests were presented at AACC 2023 (Photo courtesy of LetsGetChecked)

New research presented at the 2023 AACC Annual Scientific Meeting & Clinical Lab Expo has shown that self-collected tests are as effective as provider-collected tests in detecting prevalent sexually transmitted infections (STIs). These findings could pave the way for new, discreet testing options that expand access to STI screening.

The human papillomavirus (HPV) is a primary cause of cervical cancer in the U.S., creating the need for regular testing as part of prevention and screening measures. Testing traditionally occurs in clinical environments, but there's increasing interest in using self-collected samples for HPV and other STIs. Such self-administered tests could potentially benefit those who find it difficult to access healthcare providers due to their location, profession, or fear of stigma or discrimination. Nevertheless, additional research is needed to confirm the reliability of these self-collected tests.

Researchers from LetsGetChecked Laboratories (New York, NY, USA) and the Permanente Medical Group (Oakland, CA, USA) performed a comparative study on HPV tests using 144 pairs of self-collected vaginal swabs and healthcare provider-collected swabs from the cervix lining. Additionally, they exposed a small selection of self-collected samples to temperatures that simulate extreme seasonal fluctuations. To assess the variability in swabs from a single individual, likely due to differing virus quantities in each swab, the researchers evaluated five self-collected swabs from 15 participants.

Lastly, the team explored methods to enhance the collection process, like modifying the duration samples were left to dry and providing participants with an instructional video. The majority of self-collected samples delivered results consistent with those from provider-collected ones. Differences were attributed to smaller amounts of detectable virus in self-collected samples. Those samples exposed to extreme temperatures had less detectable virus than those not subjected to such conditions. However, changes in the drying time of samples did not affect virus detection. Sample validity saw an improvement of 8.5% after participants viewed an instructional video.

“We performed a detailed analysis of the variables related to self-collected vaginal swabs to calculate analytical acceptability metrics, and to identify limitations in testing that can be improved to aid in modern cervical cancer screening,” said primary author Michelle Qi.

In another study, researchers from the Los Angeles County Department of Public Health (Baldwin Park, CA, USA) and LetsGetChecked analyzed the performance of self-collected tests versus provider-collected tests for two common sexually transmitted infections (STIs): Chlamydia trachomatis and Neisseria gonorrhea. These infections frequently present without symptoms, making them challenging to detect. The Centers for Disease Control and Prevention suggest that self-collected samples, obtained from urine or swabs of the vagina, rectum, or throat, could serve as practical alternatives to provider-collected samples. At present, only urine and vaginal swabs can be self-collected within clinics. This research was initiated with the aim of broadening the inclusivity and accessibility of STI testing by examining more options for self-collection and home testing.

The researchers evaluated results from 164 pairs of rectal swabs collected at home and by providers, and 159 pairs of throat swabs. They also conducted tests on urine and vaginal swabs to determine the effects of temperature fluctuations, contamination from hands, and inaccurate filling of self-collected urine samples. When compared to provider-collected samples, the self-collected rectal swabs showed 95.5% positive agreement for C. trachomatis and a perfect 100% for N. gonorrhea. Meanwhile, self-collected throat swabs were nearly 100% consistent with provider-collected swabs for both infections. Notably, there were several swabs that tested positive for both pathogens when self-collected but tested negative when collected by providers. The presence of hand contaminants had a negligible impact on test outcomes, and the results remained largely unaltered by temperature fluctuations and incorrect filling of urine samples.

“Self-collected rectal and throat swabs could offer better sensitivity than those collected by physicians for detecting C. trachomatis and N. gonorrhea—without compromising the test’s analytical performance,” said Breland Hockman, Ph.D., one of the study’s authors. “Therefore, specimens of STIs collected at home offer a viable option for improving access to STI screening and could offer a non-stigmatizing approach to sexual health.”

Related Links:
LetsGetChecked Laboratories 
Permanente Medical Group 
LA County Public Health 

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Xylazine Immunoassay Test
Xylazine ELISA

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: The fastGEN BCR::ABL1 Cancer kit offers a way to personalize treatment strategies for leukemia (Photo courtesy of BioVendor MDx)

First of Its Kind NGS Assay for Precise Detection of BCR::ABL1 Fusion Gene to Enable Personalized Leukemia Treatment

The BCR::ABL1 fusion gene plays a key role in the pathogenesis of several blood cancers, particularly chronic myeloid leukemia (CML). This gene results from a chromosomal translocation that causes constitutive... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: The ASTar System has received US FDA 510(k) clearance (Photo courtesy of Q-linea AB)

Automated Sepsis Test System Enables Rapid Diagnosis for Patients with Severe Bloodstream Infections

Sepsis affects up to 50 million people globally each year, with bacteraemia, formerly known as blood poisoning, being a major cause. In the United States alone, approximately two million individuals are... Read more

Pathology

view channel
Image: The new method is quick and easy, and can also be used by non-medical personnel. (Photo courtesy of Zoratto et al. Advanced Science 2024, edited)

New Blood Test Device Modeled on Leeches to Help Diagnose Malaria

Many individuals have a fear of needles, making the experience of having blood drawn from their arm particularly distressing. An alternative method involves taking blood from the fingertip or earlobe,... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.